The hormonal treatment in prostate cancer

被引：6
作者：
Bastide, C. [1 ]
Bruyere, F. [2 ]
Karsenty, G. [3 ]
Guy, L. [4 ]
Rozet, F. [5 ]
机构：
[1] Aix Marseille Univ, Hop Nord, AP HM, Serv Urol, F-13015 Marseille, France
[2] Univ Tours, CHRU Bretonneau, PRES Ctr Val De Loire Univ, Serv Urol, F-37000 Tours, France
[3] Aix Marseille Univ, Hop Concept, AP HM, Serv Urol & Transplantat Renale, F-13385 Marseille 5, France
[4] Univ Auvergne, Hop G Montpied, Serv Urol, F-63003 Clermont Ferrand 1, France
[5] Inst Mutualiste Montsouris, Serv Urol, F-75014 Paris, France
来源：
PROGRES EN UROLOGIE | 2013年 / 23卷 / 15期
关键词：
Prostate cancer; Hormonal treatment; LHRH analogs; Degarelix; Antiandrogens; Diethylstilbestrol; Estramustin; Abiraterone acetate; Enzalutamid; ANDROGEN DEPRIVATION THERAPY; GROUP PHASE-III; BICALUTAMIDE MONOTHERAPY; CYPROTERONE-ACETATE; INCREASED SURVIVAL; RADIATION-THERAPY; MG MONOTHERAPY; CASTRATION; FLUTAMIDE; TRIAL;
D O I：
10.1016/j.purol.2013.08.325
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Aim. - To describe drugs used in the hormonal treatment (hormonotherapy) of prostate cancer. Material. - Bibliographical search was performed from the database Medline (National Library of Medicine, PubMed) and websites of the HAS and the ANSM. The search was focused on the characteristics, the mode of action, the efficiency and the side effects of the various drugs concerned. Results. - LHRH analogs and the antiandrogens remain the cornerstone in the treatment of locally advanced and metastatic prostate cancer. New therapeutic classes emerged recently (inhibitor of the synthesis of the androgen, the new antiandrogens) and allowed to grow again the limits of the hormone resistance and define the concept castration-resistant prostate cancer. Conclusion -. The hormonal treatment of the prostate cancer grew rich of new therapeutic classes which are going to change the medical care of the prostate cancer in the coming years and the urologist must play its full part. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：1246 / 1257
页数：12
相关论文
共 55 条
[31]   Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy [J].
Moul, JW ;
Wu, HY ;
Sun, L ;
McLeod, DG ;
Amling, C ;
Donahue, T ;
Kusuda, L ;
Sexton, W ;
O'Reilly, K ;
Hernandez, J ;
Chung, A ;
Soderdahl, D .
JOURNAL OF UROLOGY, 2004, 171 (03) :1141-1147
[32]   Novel agents for the therapy of castration-resistant prostate cancer: Overview of pivotal studies and new strategies to come [J].
Ouzaid, I. ;
Ravery, V. ;
Pouessel, D. ;
Culine, S. .
PROGRES EN UROLOGIE, 2013, 23 (01) :1-7
[33]   Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer [J].
Petrylak, DP ;
Tangen, CM ;
Hussain, MHA ;
Lara, PN,J ;
Jones, JA ;
Taplin, ME ;
Burch, PA ;
Berry, D ;
Moinpour, C ;
Kohli, M ;
Benson, MC ;
Small, EJ ;
Raghavan, D ;
Crawford, ED .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (15) :1513-1520
[34]  
Peyromaure M, 2010, PROG UROL, V20, P17, DOI [10.1016/j.purol.2009.09.033, 10.1016/S1166-7087(10)70042-7]
[35]   Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapy [J].
Pinover, WH ;
Horwitz, EM ;
Hanlon, AL ;
Uzzo, RG ;
Hanks, GE .
CANCER, 2003, 97 (04) :1127-1133
[36]   Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: Long-term results of RTOG 8610 [J].
Roach, Mack, III ;
Bae, Kyounghwa ;
Speight, Joycelyn ;
Wolkov, Harvey B. ;
Rubin, Phillip ;
Lee, R. Jeffrey ;
Lawton, Colleen ;
Valicenti, Richard ;
Grignon, David ;
Pilepich, Miljenko V. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) :585-591
[37]  
ROBINSON MRG, 1995, EUR UROL, V28, P273
[38]  
Rossi D, 2007, PROG UROL, V17, P287
[39]  
Ruffion A, 2003, PROG UROL, V13, P334
[40]   Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy [J].
Ryan, Charles J. ;
Smith, Matthew R. ;
de Bono, Johann S. ;
Molina, Arturo ;
Logothetis, Christopher J. ;
de Souza, Paul ;
Fizazi, Karim ;
Mainwaring, Paul ;
Piulats, Josep M. ;
Ng, Siobhan ;
Carles, Joan ;
Mulders, Peter F. A. ;
Basch, Ethan ;
Small, Eric J. ;
Saad, Fred ;
Schrijvers, Dirk ;
Van Poppel, Hendrik ;
Mukherjee, Som D. ;
Suttmann, Henrik ;
Gerritsen, Winald R. ;
Flaig, Thomas W. ;
George, Daniel J. ;
Yu, Evan Y. ;
Efstathiou, Eleni ;
Pantuck, Allan ;
Winquist, Eric ;
Higano, Celestia S. ;
Taplin, Mary-Ellen ;
Park, Youn ;
Kheoh, Thian ;
Griffin, Thomas ;
Scher, Howard I. ;
Rathkopf, Dana E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (02) :138-148
123456